cat <<EOF > content/posts/issue-1.md
---
title: "The Single-Cell Blindspot: Why scRNA-seq Alone Isn't Enough"
date: "December 21, 2025"
tags: ["SingleCell", "Multiomics", "scATACseq", "scRNAseq"]
slug: "issue-1"
---

Are you still relying solely on **single-cell RNA sequencing (scRNA-seq)** to define cell states?

It's the default approach for a reasonâ€”it's powerful, and it's not "wrong." **But it is incomplete.**

If you only look at gene expression, you're watching the biological movie after the major plot points have already been set.

![RNA vs ATAC Comparison](/public/downloads/RNA_ATAC.png)

Here's the reality of using these modalities in isolation, and why integration is no longer optionalâ€”especially in aging and disease research.

## ðŸ”¬ The scRNA-seq "Snapshot"

scRNA-seq excels at capturing transcriptomic snapshots of established cellular states.

**What it does well:**
* Identifies functional shifts
* Spots stress responses
* Defines lineage differences

**The limitation:** Expression is typically a downstream readoutâ€”the end of a regulatory cascade, not the beginning. It tells you *what changed*, but rarely *why*.

## ðŸ§¬ The scATAC-seq "Preview"

Chromatin accessibility reveals regulatory potential before genes even fire. It exposes the cell's intent.

**What it does well:**
* Shows where transcription factors can bind
* Reveals which enhancers are poised for action
* Highlights how chromatin architecture is being remodeled

**The limitation:** An accessible region doesn't guarantee transcription is happening right now. It tells you *what could change*, but not necessarily *what did*.

## ðŸ’¡ Why This Matters: The Slow Burn of Biology

Biological transitionsâ€”like aging, disease progression, or chronic stressâ€”rarely happen by flipping a single switch.

Regulatory priming (chromatin opening, transcription factor repositioning) can precede measurable transcriptional changes by extended periods. If you're not looking at chromatin, you're missing the "decision phase" of the cell and only catching the outcome.

## The Integration Rule of Thumb

* **scRNA-seq** shows what is *expressed*.
* **scATAC-seq** shows what is *possible*.
* **Together**, they reveal what is becoming *inevitable*.

In the era of multi-omics, sticking to one modality is like navigating with half a map. For deeper insights into cellular dynamics, especially in complex processes like aging and disease, integration isn't just beneficialâ€”it's essential.

**What's your take? Have you integrated scRNA and scATAC in your work?**
EOF
